US 7,557,188 B2
Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide
Hans-Peter Schwarz, Vienna (Austria); Katalin Varadi, Vienna (Austria); Peter Turecek, Klosterneuburg (Austria); Hendrik Coenraad Hemker, Maastricht (Netherlands); and Suzette Lucette Beguin, Maastricht (Netherlands)
Assigned to Baxter Innovations GmbH, Vienna (Austria)
Filed on Sep. 02, 2005, as Appl. No. 11/218,406.
Application 11/218406 is a continuation of application No. 09/424498, granted, now 7,005,502, previously published as PCT/EP98/03090, filed on May 26, 1998.
Claims priority of application No. 917/97 (AT), filed on May 28, 1997.
Prior Publication US 2006/0003921 A1, Jan. 05, 2006
Int. Cl. A61K 35/14 (2006.01); A61K 38/00 (2006.01)
U.S. Cl. 530—380  [530/383; 530/395; 514/2; 514/802; 514/822; 435/69.6; 435/13] 7 Claims
 
1. A method of treating a blood coagulation disorder comprising the step of administering a pharmaceutical preparation comprising an effective amount of a molecule selected from the group consisting of vWF-propeptide (pp-vWF) and pro-vWF to a patient.